1. American College of Medical Genetics, Standards and Guidelines for Clinical Genetics Laboratories; 2009 edition. Revised 01/2010.
  2. Clinical and Laboratory Standards Institute, Fluorescence In Situ Hybridization Methods for Clinical Laboratories, Approved Guideline. 2nd ed. CLSI Document MM07-A2. Clinical and Laboratory Standards Institute, Wayne, PA; 2013.
  3. Stein, CK. Ch. 69: Applications of Cytogenetics in Modern Pathology, in: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st ed.; 2007.
  4. Goldblum JR, Folpe AL, Weiss SW. Enzinger & Weiss’s Soft Tissue Tumors. 7th ed. Philadelphia, PA: Elsevier; 2020.
  5. Stuer J. Eine ungewohnliche Geschwulst der Ellenbogengelenhsgegend. J mang. Diss. Wurzburg. 1893.
  6. Moberger G, Nilsonne U, Friberg S. 1968. Synovial sarcoma: histologic features and prognosis. Acta Orthopaedica Scandinavica, 39:sup11:1-40. doi:10.3109/ort.1968.39.suppl111.01
  7. Nishida H, Oyama Y, Kusaba T, Kadowaki H, Arakane M, Daa T, et al. Large lung mass: cytopathological features. CytoJournal. 2019:16;23. doi:10.4103/cytojournal.cytojournal_9_18.
  8. Murphey MD, MS Gibson, BT Jennings, AM Crespo-Rodriguez, J Fanburg-Smith, DA Gajewski. From the archives of the AFIP: imaging of synovial sarcoma with radiologic-pathologic correlation. RadioGraphics. 2006;20:1543-65. doi:10.1148/rg.265065084
  9. Suurmeijer AJH, Ladanyi M, Nielsen TO. Synovial sarcoma. In: WHO classification of tumors: soft tissue and bone tumors. WHO Classification of Tumors Editorial Board. 5th ed. Lyon, France: IARC; 2020. 290-293.
  10. Kohashi K, Y Oda. Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Cancer Science. 2017;108(4):547-52. doi:10.1038/modpathol.2010.71
  11. Kang Y, Pekmezci M, Folpe AL, Ersen A, Horvai AE. Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma. Mod Pathol. 2014;27(1):55-61. doi: 10.1038/modpathol.2013.115.
  12. Kosemehmetoglu K, Vrana JA, Folpe AL. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Mod Pathol. 2009;22(7):872-8. doi: 10.1038/modpathol.2009.47
  13. Zaccarini DJ, Deng X, Tull J, Maciak C, Valente AL, Zhang S. Expression of TLE-1 and CD99 in carcinoma: pitfalls in diagnosis of synovial sarcoma. Appl Immunohistochem Mol Morphol. 2018;26(6):368-373. doiL10.1097/PAI.0000000000000436.
  14. Desar IME, Fleuren EDG, van der Graaf WTA. Systemic Treatment for Adults with Synovial Sarcoma. Curr Treat Options Oncol. 2018;19(2):13. doi:10.1007/s11864-018-0525-1
  15. Xing Z, Wei L, Jiang X, Conroy J, Glenn S, Bshara W, et al. Analysis of mutations in primary and metastatic synovial sarcoma. Oncotarget. 2018;9(96):36878-88. doi:10.18632/oncotarget.26416 
  16. de Necochea-Campion R, Zuckerman LM, Mirshahidi HR, Khosrowpour S, Chen CS, Mirshahidi S. Metastatic biomarkers in synovial sarcoma. Biomark Res. 2017;5:4. doi:10.1186/s40364-017-0083-x
  17. Jacobs AJ, Morris CD, Levin AS. 2018. Synovial sarcoma is not associated with a higher risk of lymph node metastasis compared with other soft tissue sarcomas. Clin Orthop Relat Res. 2018;476(3):589-98. doi:10.1007/s11999.0000000000000057
  18. Outani H, Nakamura T, Murata H, Stevenson J, Parry M, Gregory J, Tillman R, Jeys L, Abudu A. 2019. Localized synovial sarcoma: a single institutional study of 191 patients with a minimum follow-up of 5 years for survivors. J Surg Oncol. 2019;119:850-5. doi:10.1002/jso25417
  19. Smolle MA, Parry M, Jeys L, Abudu S, Grimer R. 2019. Synovial sarcoma: Do children do better? European J of Surgical Oncology. 45:254-60. doi:10.1016/j.ejso.2018.07.006
  20. Nielsen GP. Chi P. Malignant peripheral nerve sheath tumor. In: WHO classification of tumors: soft tissue and bone tumors. WHO Classification of Tumors Editorial Board. 5th ed. Lyon, France: IARC; 2020. 290-293.
  21. Michael C, Hiroshima K, Hjerpe A, et al. “Malignant-primary (MAL-P) (mesothelioma).” In: Chandra A, Crothers B, Kurtycz D, Schmitt F, ed. The international system for serous fluid cytopathology. Cham, Switzerland: Springer, 2020.
  22. Sauter JL, Bueno R, Dacic S, et al. “Diffuse pleural mesothelioma.” In: WHO classification of tumors: thoracic tumors. WHO Classification of Tumors Editorial Board. 5th ed. Lyon, France: IARC, 2021.